Patents by Inventor Maria Groves

Maria Groves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BINDING MOLECULES TO ARGINASE II [ARG2]
    Publication number: 20220403048
    Abstract: An isolated antigen-binding protein characterised in that it is capable of binding specifically to human Arginase II (ARG2) and inhibiting the enzyme activity of human ARG2.
    Type: Application
    Filed: August 21, 2020
    Publication date: December 22, 2022
    Applicants: Cancer Research Technology Limited, Medimmune Limited
    Inventors: Alexandra Addyman, Mark Austin, Michelle Barnard, Vincenzo Cerundolo, Denice Chan, Agata Diamandakis, Sebastian Fielder, Maria Groves, Stuart Haynes, Sarah Holt, Lesley Jenkinson, Stephanie Keswick, Fiona McLaughlin, Pooja Sharma, Yoko Shibata, Louise Slater, Jessica Whitehouse, Mark D Carr, Daniel Burschowsky, Chitra Seewooruthun
  • ANTIBODIES TO AMYLOID BETA
    Publication number: 20220251181
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: February 16, 2022
    Publication date: August 11, 2022
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgard
  • Antibodies to amyloid beta
    Patent number: 11286297
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: March 29, 2022
    Assignee: MEDIMMUNE LIMITED
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • ANTI-PrP ANTIBODIES AND USES THEREOF
    Publication number: 20210070870
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PrPC. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Application
    Filed: September 14, 2020
    Publication date: March 11, 2021
    Inventors: Matthew GARDENER, Jayne HAMMERSLEY, Maria GROVES, Gareth REES, Sadhana PODICHETTY, Andrew BILLINTON
  • ANTIBODIES TO AMYLOID BETA
    Publication number: 20210009665
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: May 1, 2020
    Publication date: January 14, 2021
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Anti-PrP antibodies and uses thereof
    Patent number: 10808034
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PrPC. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: October 20, 2020
    Assignee: MedImmune Limited
    Inventors: Matthew Gardener, Jayne Hammersley, Maria Groves, Gareth Rees, Sadhana Podichetty, Andrew Billinton
  • P2X4 ANTIBODIES & USES THEREOF
    Publication number: 20200247885
    Abstract: The invention provides antibodies that specifically bind a P2X4 polypeptide and modulate P2X4 channel activity, recombinant P2X4 polypeptides and methods for generating such polypeptides, as well as compositions and methods for generating anti-P2X4 antibodies, and methods of using P2X4 antibodies for the treatment of neuropathic pain and other indications.
    Type: Application
    Filed: April 6, 2020
    Publication date: August 6, 2020
    Inventors: Wendy A. WILLIAMS, Clare JONES, James BUTTON, John LINLEY, Harm Jan SNIJDER, Ling HUANG, Yoko SHIBATA, Sudharsan SRIDHARAN, Maria GROVES, Claire DOBSON
  • Antibodies to amyloid beta
    Patent number: 10662239
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: May 26, 2020
    Assignee: MedImmune Limited
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • P2X4 antibodies and uses thereof
    Patent number: 10654926
    Abstract: The invention provides antibodies that specifically bind a P2X4 polypeptide and modulate P2X4 channel activity, recombinant P2X4 polypeptides and methods for generating such polypeptides, as well as compositions and methods for generating anti-P2X4 antibodies, and methods of using P2X4 antibodies for the treatment of neuropathic pain and other indications.
    Type: Grant
    Filed: May 2, 2015
    Date of Patent: May 19, 2020
    Assignee: MedImmune Limited
    Inventors: Wendy A Williams, Clare Jones, James Button, John Linley, Harm Jan Snijder, Ling Huang, Yoko Shibata, Sudharsan Sridharan, Maria Groves, Claire Dobson
  • ANTI-PrP ANTIBODIES AND USES THEREOF
    Publication number: 20190062442
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PrPc. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Application
    Filed: April 4, 2017
    Publication date: February 28, 2019
    Applicant: MEDIMMUNE LIMITED
    Inventors: Matt GARDENER, Jayne HAMMERSLEY, Maria GROVES, Gareth REES, Sadhana PODICHETTY, Andrew BILLINTON
  • ANTIBODIES TO AMYLOID BETA
    Publication number: 20180105585
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: October 25, 2017
    Publication date: April 19, 2018
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • Antibodies to amyloid beta
    Patent number: 9834598
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: December 5, 2017
    Assignee: MedImmune Limited
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne, Fraser Welsh, Per-Ola Freskgärd
  • ION CHANNEL MODULATORS AND USES THEREOF
    Publication number: 20170166634
    Abstract: The invention provides antibodies that specifically bind a P2X4 polypeptide and modulate P2X4 channel activity, recombinant P2X4 polypeptides and methods for generating such polypeptides, as well as compositions and methods for generating anti-P2X4 antibodies, and methods of using P2X4 antibodies for the treatment of neuropathic pain and other indications.
    Type: Application
    Filed: May 2, 2015
    Publication date: June 15, 2017
    Applicant: Medimmune Limited
    Inventors: Wendy A WILLIAMS, Clare JONES, James BUTTON, John LINLEY, Harm Jan SNIJDER, Ling HUANG, Yoko SHIBATA, Sudharsan SRIDHARAN, Maria GROVES, Claire DOBSON
  • ANTIBODIES TO AMYLOID BETA
    Publication number: 20150299299
    Abstract: Antibody for human amyloid beta. Antibody selectively binds human amyloid beta 42 peptide over human amyloid beta 40 peptide. Antibodies specific for amyloid beta 42 as therapeutic agents for binding amyloid beta 42 peptide and treating conditions associated with amyloidosis, such as Alzheimer's disease.
    Type: Application
    Filed: October 15, 2013
    Publication date: October 22, 2015
    Inventors: Maria Groves, Suzanne Gustavsson, Kina Höglund, Chris Lloyd, Adrian Nickson, Camilla Niva, Sylvia Simon, David Lowne